SCHEMBL30097045

SCHEMBL30097045

Fc1c[nH]c2cccc(Br)c12

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.55
GPR84 Q9NQS5 4/20 0.48
FFAR1 O14842 1/20 0.48
HTR2A P28223 2/20 0.44
CLK1 P49759 3/20 0.43
CDK5 Q00535 2/20 0.43
CDK5R1 Q15078 2/20 0.43
SLC6A4 P31645 1/20 0.41
AHR P35869 1/20 0.41
HTR2C P28335 2/20 0.40
HTR2B P41595 1/20 0.40
FGFR1 P11362 1/20 0.37
FGFR2 P21802 1/20 0.37
FGFR3 P22607 1/20 0.37
PIM1 P11309 1/20 0.36
PIM3 Q86V86 1/20 0.36
PIM2 Q9P1W9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL849441 1.00 CYP2A6 (0.55) CYP2A6GPR84FFAR1HTR2ACLK1
SCHEMBL28973447 0.80 CYP2A6 (0.60) CYP2A6GPR84FFAR1HTR2ACLK1
SCHEMBL31332574 0.75 GPR84 (0.58) GPR84FFAR1HTR2ASLC6A4HTR2C
SCHEMBL17308781 0.75 GPR84 (0.58) GPR84FFAR1HTR2ASLC6A4HTR2C
SCHEMBL15826665 0.75 GPR84 (0.58) GPR84FFAR1HTR2ASLC6A4HTR2C
SCHEMBL3614670 0.75 CYP2A6 (0.55) CYP2A6GPR84FFAR1HTR2ACLK1
SCHEMBL31663257 0.75 CYP2A6 (0.55) CYP2A6GPR84FFAR1HTR2ACLK1
SCHEMBL13544712 0.75 CYP2A6 (0.55) CYP2A6GPR84FFAR1CLK1CDK5
SCHEMBL19400908 0.75 CYP2A6 (0.55) CYP2A6GPR84FFAR1HTR2ACLK1
SCHEMBL28879718 0.75 CYP2A6 (0.59) CYP2A6GPR84FFAR1CLK1CDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120192307-A Compounds targeting p53 mutations 上海齐鲁制药研究中心有限公司 2025-06-24 CN disclosed
EP-4096667-A1 COMPOUNDS AND USES THEREOF Foghorn Therapeutics Inc. (US) 2022-12-07 EP disclosed